Search

everythinglearnresearchcommunity

for

Search:↓

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

New treatments for hair loss may target specific pathways and generate new hair follicles.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

PRP therapy works better than minoxidil for treating hair loss.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.